Przemyslaw Twardowski is an Oncology physician. ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery
Sponsor: National Cancer Institute (NCI)
- Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer
Sponsor: City of Hope Medical Center
- Etoposide and Celecoxib in Patients With Advanced Cancer
Sponsor: City of Hope Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
48 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year202546 payments$60,369openpaymentsdata.cms.gov ↗
- Janssen Biotech, Inc.Program year202544 payments$30,372openpaymentsdata.cms.gov ↗
- Bayer Healthcare Pharmaceuticals Inc.Program year202518 payments$27,459openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2004–2023 per NIH RePORTER. The latest:
- (PQ11) Immune modulatory effects of white button mushroom in prostate cancer - A translational research
Beckman Research Institute/city of Hope
FY2023$644,198R01CA227230 - (PQ11) Immune modulatory effects of white button mushroom in prostate cancer - A translational research
Beckman Research Institute/city of Hope
FY2022$655,944R01CA227230 - (PQ11) Immune modulatory effects of white button mushroom in prostate cancer - A translational research
Beckman Research Institute/city of Hope
FY2021$670,823R01CA227230
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”